In this episode, Darcy Wooten, MD, discusses new HIV data from IDWeek 2021, including:A rapid test-and-treat program to start DTG/3TC in patients newly diagnosed with HIV (STAT)Efficacy when switching from 3-drug to 4-drug TAF-based regimens to DTG/3TC (TANGO)Virologic outcomes with 2-drug vs 3-drug ART regimens (Trio Health HIV Network Study)Metabolic complications in treatment-naive patients (Study 1489 and Study 1490)Resistance analysis of an investigational agent, lenacapavir (CALIBRATE)The Positive Perspectives Survey to evaluate the U=U Educational Campaign in North American patientsPresenter:Darcy Wooten, MDAssociate Professor of MedicineDivision of Infectious Diseases and Global Public HealthDepartment of MedicineUniversity of California, San DiegoSan Diego, CaliforniaLink to full program:https://bit.ly/3BCHF2E Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related